Today’s Caribbean Current: Cancer Care in the Caribbean as a Health System Investment
Cancer care in the Caribbean is often discussed in terms of gaps and unmet need. But emerging evidence shows it is also one of the strongest opportunities to strengthen health systems, improve equity, and build regional resilience. Cancer is now the second leading cause of death in the Caribbean. But the most important question is not how big the problem is, it is what cancer care makes possible for the health system as a whole.
A major regional analysis in The Lancet Oncology demonstrates that the Caribbean already has several of the foundational elements needed to improve cancer outcomes: emerging cancer registries, regional clinical guidelines, public–private partnerships, and cross-border collaboration. The opportunity lies in how these elements are connected and scaled.
Recent global evidence reinforces this point. A 2026 analysis in the Journal of the National Cancer Institute (JNCI) argues that cancer should no longer be treated primarily as a clinical problem, but as a strategic health-system investment, one that strengthens prevention, financing, workforce capability, data infrastructure, and equity across the entire system.
1. Cancer as a Lever for Health-system Strengthening
Cancer care touches nearly every part of the health system: primary care, diagnostics, imaging, surgery, pharmaceuticals, palliative care, data systems, and financing. Investments made for cancer rarely stay siloed.
v xZIn the Caribbean context, this means:
- Strengthening early detection and referral pathways improves performance for all non-communicable diseases
- Building cancer registries improves national health intelligence and planning capacity
- Developing resource-appropriate clinical guidelines sets a template for other complex conditions
The Lancet Caribbean analysis shows that modest, system-level improvements, particularly in early diagnosis and coordination, could deliver disproportionately large gains in survival, even without high-cost technologies.
2. Multidisciplinary Care is Scalable in Small Systems
Evidence from multiple settings shows that multidisciplinary cancer care improves guideline adherence, coordination, and efficiency (not just outcomes). Importantly, multidisciplinary models do not require large populations to function well; in fact, smaller systems may benefit more from formal coordination mechanisms.
Reviews of lung cancer multidisciplinary teams show reductions in unnecessary testing, better treatment sequencing, and more efficient use of specialist time when care is coordinated through structured teams and pathways.
For the Caribbean, where specialist availability is limited, regional and virtual multidisciplinary models represent a realistic and cost-effective way to extend expertise without duplicating infrastructure.
3. Digital Health and AI: Opportunity, not Replacement
Digital health and artificial intelligence are often framed as expensive, high-tech solutions. However, recent global reviews show that their highest value in resource-constrained systems is not cutting-edge precision medicine, but efficiency, access, and coordination.
Evidence from low- and middle-income settings demonstrates that:
- Telemedicine expands specialist reach and supports regionalisation of care
- Digital registries and interoperable records improve continuity and planning
- AI tools are most valuable when used to reduce bottlenecks, not simply add new services
Crucially, ethical analyses caution that AI investments must be aligned with equity goals, prioritising earlier diagnosis, outreach, and navigation rather than reinforcing existing access gaps.
For the Caribbean, this supports a phased digital strategy: build data foundations first, deploy AI selectively where it saves time or cost, and reinvest efficiency gains into prevention and access.
4. Cancer Financing as a Discipline, Not a Reaction
One of the strongest arguments from the JNCI analysis is that cancer control must be aligned with explicit fiscal and operational planning. Unplanned cancer spending drives inefficiency, household impoverishment, and system instability.
In small island states and small country systems, this creates an opportunity to:
- Use cancer care as a test case for strategic purchasing and regional pooling
- Integrate cancer services into broader universal health coverage frameworks
- Design benefit packages that reward early detection and coordinated care
When cancer is treated as a predictable system investment rather than an emergency cost, it becomes a stabilising force rather than a fiscal threat.
A Caribbean Opportunity, Not a Deficit
The evidence does not suggest that the Caribbean needs to “catch up” by replicating large-country cancer systems. Instead, it shows that small systems can move faster, by aligning cancer control with system design, regional collaboration, digital foundations, and disciplined financing.
Cancer care, done well, is not just about survival. It is one of the most powerful entry points for building resilient, equitable health systems in the Caribbean.
Select Sources
Dako, F., Moraes, F. Y., Doo, F., Abed, M., Anazodo, U., Patrick, L., Favorito, F. M., Fouad, E., Alabi, A., Avery, S., Scott, A., Ngwa, W., & Hricak, H. (2025). Digital health and artificial intelligence innovations for oncology in sub-Saharan Africa. The Lancet Oncology, 26, e547–e557. https://doi.org/10.1016/S1470-2045(25)00360-2
Essue, B. M., Gheorghe, A., Rodin, G., & Sullivan, R. (2026). Re-envisioning the value proposition for investment in cancer care. Journal of the National Cancer Institute, 118(1), 12–17. https://doi.org/10.1093/jnci/djaf199
Rankin, N. M., Fradgley, E. A., & Barnes, D. J. (2020). Implementation of lung cancer multidisciplinary teams: A review of evidence–practice gaps. Translational Lung Cancer Research, 9(4), 1667–1679. https://doi.org/10.21037/tlcr.2019.11.32
Roadevin, C., & Hill, H. (2025). AI interventions in cancer screening: Balancing equity and cost-effectiveness. Journal of Medical Ethics. Advance online publication. https://doi.org/10.1136/jme-2025-110707
Spence, D., Argentieri, M. A., Andall-Brereton, G., Anderson, B. O., Duggan, C., Bodkyn, C., Bray, F., Gibson, T., Gomez Garcia, W., Greaves, N., Gupta, S., Hobday, V., McLean, F., Mery, L., Nimrod, M., Ocho, O., Sin Quee-Brown, C., Tortolero-Luna, G., & Shields, A. E. (2019). Advancing cancer care and prevention in the Caribbean: A survey of strategies for the region. The Lancet Oncology, 20, e522–e534. https://doi.org/10.1016/S1470-2045(19)30516-9
Share:
